Anxiety treatment serving Highland Beach — exposure-based CBT, in-house psychiatry.

From Highland Beach, RECO's Delray Beach campus is a twelve-minute drive up A1A — close enough that a Bel Lido Isle or Toscana resident can attend PHP or IOP without relocating. The clinical model treats anxiety as a specific DSM-5-TR diagnosis: GAD-7, PDSS, LSAS, or Y-BOCS on intake, exposure-based CBT matched to the disorder, and SSRI pharmacotherapy dosed at the anxiety-effective range by an in-house psychiatrist. Benzodiazepines are used sparingly, never as a substitute for the exposure work.

Highland Beach sits as a narrow, three-mile ribbon of oceanfront between Delray and Boca Raton — quiet by design, and roughly twelve minutes up A1A from RECO Health’s Delray Beach campus. For residents of Bel Lido Isle, Toscana, Boca Cove, Ocean Cove, and the Penthouse, that drive puts specialist-level partial hospitalization, intensive outpatient, and in-house addiction psychiatry within reach of a lunch hour. General behavioral-health practices in Boca can hold a weekly session; a structured anxiety program delivers something different.

Disorder-specific assessment before treatment starts

“Anxiety” is a symptom, not a diagnosis, and the diagnosis dictates the protocol. RECO’s psychiatric intake uses the GAD-7 for generalized anxiety severity, the Panic Disorder Severity Scale (PDSS) for panic frequency and functional impairment, the Liebowitz Social Anxiety Scale (LSAS) for social anxiety, and the Y-BOCS for obsessive-compulsive symptom burden. Every treatment plan names the primary DSM-5-TR diagnosis, the comorbid conditions if any, and the specific outcome measure that will be repeated at defined intervals.

The distinction matters because the treatments diverge. Generalized anxiety responds to a different exposure structure than OCD; social anxiety treatment collapses when it is run as a generic mixed-anxiety group. A client whose primary problem is OCD but who was mislabeled with GAD in a prior setting frequently arrives having tried multiple SSRIs at subtherapeutic doses without any structured Exposure and Response Prevention — the intervention that would have actually moved the Y-BOCS score.

The intake also screens for the confounders that drive most anxiety-treatment failures: unrecognized bipolar spectrum illness where SSRI monotherapy risks activation, adult ADHD (ASRS) presenting as chronic worry, thyroid dysfunction, stimulant or alcohol use that mimics or amplifies anxiety, and PTSD masquerading as panic. When co-occurring substance use is present, ASAM Criteria dimensions determine whether partial hospitalization or intensive outpatient is the appropriate starting level of care.

SSRI pharmacotherapy at anxiety-appropriate doses

Sertraline, escitalopram, paroxetine, and fluoxetine each carry FDA approval for one or more anxiety disorders, and they remain the first-line pharmacologic option across GAD, panic disorder, social anxiety disorder, and OCD. Anxiety-effective dosing typically sits at the upper end of the depression range — sertraline 150-200 mg, escitalopram 20 mg, fluoxetine 40-60 mg for OCD — with a deliberately slow initial titration to avoid the transient activation that causes patients to abandon treatment in the first two weeks.

Buspirone is a reasonable augmentation for residual generalized anxiety when an SSRI has produced a partial response. Hydroxyzine covers as-needed use without benzodiazepine risk. Propranolol has a defined role in situational performance anxiety, particularly for clients whose panic fires around a discrete predictable trigger. For OCD, adjunctive low-dose aripiprazole is supported when SSRI monotherapy at maximum tolerated dose has produced an inadequate Y-BOCS reduction after twelve weeks.

Medication is reviewed by the treating psychiatrist — not signed off by a rotating prescriber — and dose changes are tied to the outcome measure rather than to subjective report alone. If the GAD-7 is not moving after six to eight weeks at a therapeutic dose, that is a data point that drives the next decision, whether a switch, an augmentation, or a reformulated diagnosis.

Exposure-based CBT is the therapy that works

For every anxiety disorder in the DSM-5-TR, the strongest evidence base points to exposure-based cognitive behavioral therapy rather than supportive talk therapy. RECO’s anxiety treatment program builds each client’s individual therapy around the protocol matched to the diagnosis: Exposure and Response Prevention (ERP) for OCD, structured and hierarchical; interoceptive exposure to feared bodily sensations for panic disorder; graded in-vivo exposure paired with cognitive restructuring for social anxiety disorder; and applied relaxation with worry-exposure work for generalized anxiety.

Group programming at the PHP and IOP levels supports the individual exposure work rather than replacing it. Skills groups draw from CBT, DBT distress tolerance, and Acceptance and Commitment Therapy (ACT) — useful frames, but they do not substitute for the therapist-guided exposure hierarchy that actually extinguishes the fear response. Clients whose primary problem is trauma-linked anxiety are referred into EMDR or trauma-focused CBT tracks; motivational interviewing addresses ambivalence in clients hesitant to engage in exposure work.

The pace is calibrated to the diagnosis. OCD ERP moves through a hierarchy of feared stimuli the client and therapist construct together; panic work often produces measurable change inside three to four weeks of daily interoceptive practice; social anxiety improvement tracks with the count of completed in-vivo exposures rather than with elapsed calendar time.

Why we don’t lean on benzodiazepines

Benzodiazepines relieve acute anxiety within an hour, and that is precisely the problem. They blunt the extinction learning that exposure therapy depends on — a client who takes lorazepam before a feared exposure is not learning that the situation is tolerable; they are learning that the medication is necessary. The exposure protocol runs, but the therapeutic mechanism does not.

The class also carries meaningful risk in clients with any co-occurring substance use disorder, which describes a significant share of RECO’s population. Cross-tolerance with alcohol and opioids, respiratory depression risk in combination, and the well-documented difficulty of tapering long-term users make benzodiazepines a poor default in a dual-diagnosis setting. When genuine situational bridging is needed — the first days of an SSRI titration, an unavoidable feared event before exposure work has taken hold — hydroxyzine, gabapentin, or a short course of a low-dose beta-blocker cover most use cases without the dependence trajectory.

What to expect on the first visit

The first day includes a full psychiatric evaluation, a therapy intake, and a medical screen. The psychiatrist establishes the primary anxiety diagnosis, screens for the confounders above, reviews any current medications for dose adequacy, and outlines the pharmacologic plan. The therapist administers the disorder-specific measure — GAD-7, PDSS, LSAS, or Y-BOCS — and begins building the exposure hierarchy that will structure individual sessions.

Level of care is not decided by insurance authorization alone. Clients whose anxiety has collapsed occupational or academic functioning, or who are unable to leave the house without a safety companion, typically start at partial hospitalization (roughly six hours daily, five days per week) and step down to intensive outpatient as the outcome measure improves. Clients maintaining partial function usually begin at IOP.

Insurance and admissions from Highland Beach

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS, and admissions runs verification of benefits the same day a prospective client calls. From Highland Beach, the drive to the Delray Beach campus is roughly twelve minutes up A1A or Federal Highway — short enough that PHP schedules are workable for residents of Bel Lido Isle, Toscana, and the oceanfront condominium buildings without disrupting the family or household routine that treatment is ultimately meant to protect.

Serving residents of: Bel Lido Isle, Boca Cove, Ocean Cove, Toscana, Penthouse.